Evidence map›Paper›PMID 29436434›Full record

ReviewClinical medicine (London, England)2018

Updates in palliative care - overview and recent advancements in the pharmacological management of cancer pain.

Helen Wood, Andrew Dickman, Angela Star, Jason W Boland

Open access · diamondAbstract readReview
In one paragraph

Review in Clinical medicine (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Application of interdisciplinary collaborative hospice care for terminal geriatric cancer patients: a prospective randomized controlled study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Trial
  4. Awake Percutaneous Cervical Cordotomy in Patients With Cancer: A Technical Report.Pain practice : the official journal of World Institute of Pain · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Helen WoodRoyal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK jason.boland@hyms.ac.uk.
Andrew DickmanRoyal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Angela StarSheffield Teaching Hospitals, Sheffield, UK.
Jason W BolandWolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.
Royal Liverpool and Broadgreen University Hospital NHS Trust · GBSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity of Hull · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain is a common symptom in many types of cancer. Interdisciplinary team management, including pain assessment, explanation to the patient/family, treating the reversible, non-pharmacological treatments and reassessment are essential. This article focuses on the pharmacological management of cancer pain, and overviews and updates on the recent advances in this field. Both non-opioid and opioid analgesia as well as coanalgesics (adjuvants) are reviewed. Within non-opioid analgesia the risks of non-steroidal anti-inflammatory drugs (NSAIDs) are considered and recommendations for NSAIDs in patients at risk of gastrointestinal and cardiovascular toxicity are made. For opioid analgesics, side effects of opioids are discussed alongside practical guidance on opioid prescribing and converting between opioids. Newer drugs such as tapentadol are considered in this update. Amitriptyline, duloxetine, gabapentin and pregabalin, and the guidance for their use are reviewed in the coanalgesics (adjuvants) section.

Indexed as

Cancer PainMedication Therapy ManagementHumansPain ManagementPain MeasurementPalliative Careanalgesicsneoplasmsnon-steroidal anti-inflammatory agentsopioidPaintapentadol

Identifiers

PMID29436434
PMCPMC6330928
OpenAlexW2786986692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.